Christiana Davis

1.1k total citations
20 papers, 715 citations indexed

About

Christiana Davis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Christiana Davis has authored 20 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Christiana Davis's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Christiana Davis is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Christiana Davis collaborates with scholars based in United States and Canada. Christiana Davis's co-authors include Corey J. Langer, Charuhas Deshpande, Christine Ciunci, Charu Aggarwal, Roger B. Cohen, Joshua Bauml, Evan Alley, Jeffrey C. Thompson, Tracey L. Evans and Rosemarie Mick and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Free Radical Biology and Medicine.

In The Last Decade

Christiana Davis

18 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christiana Davis United States 11 381 357 188 124 115 20 715
Chih‐Liang Wang Taiwan 18 343 0.9× 336 0.9× 349 1.9× 68 0.5× 127 1.1× 60 847
Yutaka Shio Japan 12 250 0.7× 197 0.6× 141 0.8× 114 0.9× 122 1.1× 53 493
Yunhong Tian China 11 293 0.8× 208 0.6× 160 0.9× 59 0.5× 89 0.8× 19 562
Anne S. Quante Germany 12 369 1.0× 94 0.3× 213 1.1× 87 0.7× 117 1.0× 30 695
Masahiro Morise Japan 17 707 1.9× 752 2.1× 206 1.1× 68 0.5× 141 1.2× 112 1.1k
Filippos Koinis Greece 17 684 1.8× 252 0.7× 257 1.4× 286 2.3× 235 2.0× 43 997
J Nakashima Japan 4 209 0.5× 188 0.5× 141 0.8× 97 0.8× 143 1.2× 5 459
Johannes Stein Germany 10 171 0.4× 180 0.5× 187 1.0× 105 0.8× 74 0.6× 33 467
Sara Junius Belgium 6 233 0.6× 144 0.4× 109 0.6× 94 0.8× 62 0.5× 8 475
Marco Johannes Battista Germany 18 426 1.1× 154 0.4× 245 1.3× 148 1.2× 205 1.8× 76 998

Countries citing papers authored by Christiana Davis

Since Specialization
Citations

This map shows the geographic impact of Christiana Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christiana Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christiana Davis more than expected).

Fields of papers citing papers by Christiana Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christiana Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christiana Davis. The network helps show where Christiana Davis may publish in the future.

Co-authorship network of co-authors of Christiana Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Christiana Davis. A scholar is included among the top collaborators of Christiana Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christiana Davis. Christiana Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Jeffrey C., Caitlin M. Tilsed, Christiana Davis, et al.. (2024). Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients. Cancers. 16(16). 2795–2795. 1 indexed citations
2.
Bauml, Joshua, Christiana Davis, Lova Sun, et al.. (2024). OA06.04 Phase II Study of Pembrolizumab and Itacitinib for Patients with Metastatic NSCLC Expressing PD-L1: Long-Term Follow up. Journal of Thoracic Oncology. 19(10). S20–S20.
3.
Davis, Christiana, Christine Ciunci, Charu Aggarwal, et al.. (2024). Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC. JTO Clinical and Research Reports. 5(6). 100667–100667. 3 indexed citations
4.
Yegya‐Raman, Nikhil, Siqi Zhang, Roger B. Cohen, et al.. (2023). Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression. Clinical Lung Cancer. 25(1). 50–60.e6. 7 indexed citations
5.
Mileham, Kathryn F., Suanna S. Bruinooge, Charu Aggarwal, et al.. (2021). Mortality risk for patients undergoing cancer treatment who acquire SARS-CoV-2: ASCO registry.. Journal of Clinical Oncology. 39(15_suppl). 6509–6509. 1 indexed citations
6.
Mileham, Kathryn F., Suanna S. Bruinooge, Charu Aggarwal, et al.. (2021). Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry. JCO Oncology Practice. 18(4). e426–e441. 13 indexed citations
7.
Sun, Lova, Christiana Davis, Wei‐Ting Hwang, et al.. (2020). Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy. Clinical Lung Cancer. 22(1). 58–66.e3. 30 indexed citations
8.
Thompson, Jeffrey C., Christiana Davis, Wei‐Ting Hwang, et al.. (2020). Gene signature of antigen processing and presentation machinery (APM) as highly predictive of response to checkpoint blockade in lung cancer and melanoma.. Journal of Clinical Oncology. 38(15_suppl). 3121–3121. 1 indexed citations
9.
Thompson, Jeffrey C., Christiana Davis, Charuhas Deshpande, et al.. (2020). Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma. Journal for ImmunoTherapy of Cancer. 8(2). e000974–e000974. 66 indexed citations
10.
Sun, Lova, Christiana Davis, Melina E. Marmarelis, et al.. (2020). Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.. Journal of Clinical Oncology. 38(15_suppl). 9599–9599. 2 indexed citations
11.
Thompson, Jeffrey C., Wei‐Ting Hwang, Christiana Davis, et al.. (2019). Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy. Lung Cancer. 139. 1–8. 93 indexed citations
12.
Kier, Melanie Wain, Melina E. Marmarelis, Christiana Davis, et al.. (2019). P1.01-63 Impact of Prior Radiation Pneumonitis on Incidence of Immunotherapy Related Pneumonitis. Journal of Thoracic Oncology. 14(10). S383–S384.
13.
Bauml, Joshua, Rosemarie Mick, Christine Ciunci, et al.. (2019). Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer. JAMA Oncology. 5(9). 1283–1283. 217 indexed citations
14.
Aggarwal, Charu, Christiana Davis, Rosemarie Mick, et al.. (2018). Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non–Small-Cell Lung Cancer. JCO Precision Oncology. 2018(2). 1–29. 64 indexed citations
15.
Ciunci, Christine, Charu Aggarwal, Christiana Davis, et al.. (2018). OA07.01 Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT). Journal of Thoracic Oncology. 13(10). S335–S336. 2 indexed citations
16.
Hawkins, Brian J., Mark Levin, Patrick J. Doonan, et al.. (2010). Mitochondrial Complex II Prevents Hypoxic but Not Calcium- and Proapoptotic Bcl-2 Protein-induced Mitochondrial Membrane Potential Loss. Journal of Biological Chemistry. 285(34). 26494–26505. 37 indexed citations
17.
Davis, Christiana, Brian J. Hawkins, Subbiah Ramasamy, et al.. (2009). Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radical Biology and Medicine. 48(2). 306–317. 98 indexed citations
18.
Davis, Christiana, Linda W. Gonzales, Roberta A. Ballard, et al.. (2008). Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia. Pediatric Pulmonology. 43(7). 703–709. 16 indexed citations
19.
Gow, Andrew J., Christiana Davis, David Munson, & Harry Ischiropoulos. (2004). Immunohistochemical Detection of <I>S</I>-Nitrosylated Proteins. Humana Press eBooks. 279. 167–172. 17 indexed citations
20.
Atochina‐Vasserman, Elena N., Michael F. Beers, Samuel Hawgood, et al.. (2003). Surfactant Protein-D, a Mediator of Innate Lung Immunity, Alters the Products of Nitric Oxide Metabolism. American Journal of Respiratory Cell and Molecular Biology. 30(3). 271–279. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chih‐Liang Wang Breakdown of academic impact, for papers by Yutaka Shio Breakdown of academic impact, for papers by Yunhong Tian Breakdown of academic impact, for papers by Anne S. Quante Breakdown of academic impact, for papers by Masahiro Morise Breakdown of academic impact, for papers by Filippos Koinis Breakdown of academic impact, for papers by J Nakashima Breakdown of academic impact, for papers by Johannes Stein Breakdown of academic impact, for papers by Sara Junius Breakdown of academic impact, for papers by Marco Johannes Battista
Rankless by CCL
2026